MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.antiviral.2025.106221

Медицинская библиотека · Antiviral research · 2025

LAVR-289, a broad-spectrum antiviral, protects immunosuppressed Syrian hamsters against lethal adenovirus challenge.

Tollefson Ann E, Cline-Smith Anna, Roy Vincent, Agrofoglio Luigi A, Abate Getahun, Gallardo Franck, Toth Karoly

СтатьяПеревод в очереди

Аннотация

LAVR-289, a newly described acyclic nucleoside phosphonate prodrug, has previously shown in vitro efficacy against adenovirus (HAdV) species B, C, D, E, and F with EC50 values of 100 nM to 1.2 μM. The compound was efficacious prophylactically against systemic HAdV infection in immunosuppressed Syrian hamsters. Here, we present further, more detailed data on its efficacy against HAdV. We tested the two enantiomers at chiral phosphorus center (Sp and Rp) of LAVR-289 and found that both stereoisomers were equally efficacious against HAdV-C5 and -C6 infecting human foreskin fibroblast primary cells in vitro, indicating that the racemic mixture of the compound could be used as a drug. Following these favorable in vitro results, the antiviral activity of racemic LAVR-289 was evaluated in the immunosuppressed Syrian hamster model, in which the hamsters were challenged with the intravenous LD90 dose of HAdV-C6. Prophylactic administration of LAVR-289 completely prevented mortality at doses of 24 mg/kg p.o. q.d. or higher. At the efficacious dose levels, it significantly inhibited virus replication in the liver and mitigated HAdV-C6-induced liver damage. As prophylactic administration may not be advisable in a clinical setting, we delayed the administration of LAVR-289 and showed that the compound prevented mortality and significantly reduced morbidity even when the drug was withheld for 3 days post challenge. Based on these results, we believe that these data demonstrate in vitro and in vivo potency of LAVR-289 against HAdVs and support its continued development.

Для цитирования: Tollefson Ann E, Cline-Smith Anna, Roy Vincent, Agrofoglio Luigi A, Abate Getahun, Gallardo Franck, Toth Karoly. LAVR-289, a broad-spectrum antiviral, protects immunosuppressed Syrian hamsters against lethal adenovirus challenge.. Antiviral research. 2025. DOI: 10.1016/j.antiviral.2025.106221.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.